Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stavanger University Hospital IBD Study - a Cross Sectional Longitudinal Study on Patients Treated With Biologics

NCT02134054 is registered in ClinicalTrials.gov with Helse Stavanger HF as lead sponsor.

NCT NCT02134054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02134054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stavanger University Hospital IBD Study - a Cross Sectional Longitudinal Study on Patients Treated With Biologics
Lead sponsor
Helse Stavanger HF
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2014
Completion date
December 31, 2024
Enrollment
210 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel disease